Success Metrics

Completion Rate
0%(0/3)
Active Trials
0(0%)
Terminated
3(75%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 4 finished

Non-Completion Rate

100.0%

4 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Terminated(4)

Detailed Status

Terminated3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

terminated375%
withdrawn125%

Recent Activity

0 active trials
Showing 4 of 4
terminatednot_applicable

Use of 3M Cavilon Advanced Skin Protectant in the Management of Damaged Skin Around an Ostomy, Drain or Fistula

NCT03057132
terminatednot_applicable

Comparative Study to Assess an Advanced Skin Protectant in the Management of Incontinence-associated Dermatitis

NCT03298113
terminatednot_applicable

Clinical Study to Assess a New Barrier Film's Ability to Provide Skin Protection Against Incontinence & Allow Healing

NCT02570139
withdrawnnot_applicable

A Novel Skin Barrier Protectant for Acute Radiodermatitis

NCT04593914

Clinical Trials (4)

Showing 4 of 4 trials
NCT03057132Not Applicable

Use of 3M Cavilon Advanced Skin Protectant in the Management of Damaged Skin Around an Ostomy, Drain or Fistula

Terminated
NCT03298113Not Applicable

Comparative Study to Assess an Advanced Skin Protectant in the Management of Incontinence-associated Dermatitis

Terminated
NCT02570139Not Applicable

Clinical Study to Assess a New Barrier Film's Ability to Provide Skin Protection Against Incontinence & Allow Healing

Terminated
NCT04593914Not Applicable

A Novel Skin Barrier Protectant for Acute Radiodermatitis

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4